Huynh H - Search Results

1

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.

Huynh H, Chow PK, Palanisamy N, Salto-Tellez M, Goh BC, Lee CK, Somani A, Lee HS, Kalpana R, Yu K, Tan PH, Wu J, Soong R, Lee MH, Hor H, Soo KC, Toh HC, Tan P. Huynh H, et al. J Hepatol. 2008 Jul;49(1):52-60. doi: 10.1016/j.jhep.2008.02.022. Epub 2008 Apr 28. J Hepatol. 2008. PMID: 18490075

2

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.

Huynh H, Nguyen TT, Chow KH, Tan PH, Soo KC, Tran E. Huynh H, et al. BMC Gastroenterol. 2003 Aug 8;3:19. doi: 10.1186/1471-230X-3-19. BMC Gastroenterol. 2003. PMID: 12906713 Free PMC article.

3

Xenografts of human hepatocellular carcinoma: a useful model for testing drugs.

Huynh H, Soo KC, Chow PK, Panasci L, Tran E. Huynh H, et al. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4306-14. doi: 10.1158/1078-0432.CCR-05-2568. Clin Cancer Res. 2006. PMID: 16857806

4

Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.

Huynh H, Soo KC, Chow PK, Tran E. Huynh H, et al. Mol Cancer Ther. 2007 Jan;6(1):138-46. doi: 10.1158/1535-7163.MCT-06-0436. Mol Cancer Ther. 2007. PMID: 17237274

5

AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma.

Huynh H, Chow PK, Soo KC. Huynh H, et al. Mol Cancer Ther. 2007 Sep;6(9):2468-76. doi: 10.1158/1535-7163.MCT-07-0162. Mol Cancer Ther. 2007. PMID: 17876044

6

Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer.

Huynh H, Teo CC, Soo KC. Huynh H, et al. Mol Cancer Ther. 2007 Nov;6(11):2959-66. doi: 10.1158/1535-7163.MCT-07-0237. Mol Cancer Ther. 2007. PMID: 18025280

7

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma.

Huynh H, Chow KH, Soo KC, Toh HC, Choo SP, Foo KF, Poon D, Ngo VC, Tran E. Huynh H, et al. J Cell Mol Med. 2009 Jul;13(7):1371-80. doi: 10.1111/j.1582-4934.2008.00364.x. Epub 2008 May 7. J Cell Mol Med. 2009. PMID: 18466352 Free PMC article.

8

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor.

Huynh H, Lee JW, Chow PK, Ngo VC, Lew GB, Lam IW, Ong HS, Chung A, Soo KC. Huynh H, et al. Mol Cancer Ther. 2009 Jan;8(1):152-9. doi: 10.1158/1535-7163.MCT-08-0553. Mol Cancer Ther. 2009. PMID: 19139124

9

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).

Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Toh HC, Thng CH, Chow P, Ong HS, Chung A, Goh BC, Smith PD, Soo KC. Huynh H, et al. J Hepatol. 2010 Jan;52(1):79-87. doi: 10.1016/j.jhep.2009.10.008. Epub 2009 Oct 28. J Hepatol. 2010. PMID: 19910069

10

Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma.

Huynh H, Chow PK, Tai WM, Choo SP, Chung AY, Ong HS, Soo KC, Ong R, Linnartz R, Shi MM. Huynh H, et al. J Hepatol. 2012 Mar;56(3):595-601. doi: 10.1016/j.jhep.2011.09.017. Epub 2011 Oct 23. J Hepatol. 2012. PMID: 22027573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters